In conclusion, SDF2L1 may act as a cancer suppressor gene, play a crucial role in the occurrence and development of NPC, and be a new therapeutic target or prognostic indicator for NPC. The gene discussed is SDF2L1; the disease is nasopharyngeal carcinoma.